| Literature DB >> 34127497 |
Sophie Moog1,2, Aurélie Morin1,2, Judith Goncalves1,2, Géraldine Gentric3, Sebastian Müller4, Alexander P Morrell5, Katarina Kluckova6, Theodora J Stewart7, Cynthia L Andoniadou8, Charlotte Lussey-Lepoutre1,9, Paule Bénit10, Alpesh Thakker6, Lisa Vettore6, Jennie Roberts6, Raphaël Rodriguez4, Fatima Mechta-Grigoriou3, Anne-Paule Gimenez-Roqueplo1,2,11, Eric Letouzé12, Daniel A Tennant6, Judith Favier13,2.
Abstract
Succinate dehydrogenase is a key enzyme in the tricarboxylic acid cycle and the electron transport chain. All four subunits of succinate dehydrogenase are tumor suppressor genes predisposing to paraganglioma, but only mutations in the SDHB subunit are associated with increased risk of metastasis. Here we generated an Sdhd knockout chromaffin cell line and compared it with Sdhb-deficient cells. Both cell types exhibited similar SDH loss of function, metabolic adaptation, and succinate accumulation. In contrast, Sdhb-/- cells showed hallmarks of mesenchymal transition associated with increased DNA hypermethylation and a stronger pseudo-hypoxic phenotype compared with Sdhd-/- cells. Loss of SDHB specifically led to increased oxidative stress associated with dysregulated iron and copper homeostasis in the absence of NRF2 activation. High-dose ascorbate exacerbated the increase in mitochondrial reactive oxygen species, leading to cell death in Sdhb-/- cells. These data establish a mechanism linking oxidative stress to iron homeostasis that specifically occurs in Sdhb-deficient cells and may promote metastasis. They also highlight high-dose ascorbate as a promising therapeutic strategy for SDHB-related cancers. SIGNIFICANCE: Loss of different succinate dehydrogenase subunits can lead to different cell and tumor phenotypes, linking stronger 2-OG-dependent dioxygenases inhibition, iron overload, and ROS accumulation following SDHB mutation. ©2021 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34127497 DOI: 10.1158/0008-5472.CAN-20-2936
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701